Recent reports have proposed a new paradigm for obtaining mature somatic cell types from fibroblasts without going through a pluripotent state, by briefly expressing canonical iPSC reprogramming factors Oct4, Sox2, Klf4, in cells expanded in lineage differentiation promoting conditions. Here we apply genetic lineage tracing for endogenous Nanog locus and X chromosome reactivation during OSKM induced trans-differentiation, as these molecular events mark final stages for acquisition of induced pluripotency. Remarkably, the majority of reprogrammed cardiomyocytes or neural stem cells derived from mouse fibroblasts via OSKM mediated trans-differentiation (~>90%), are attained after transient acquisition of pluripotency, and followed by rapid differentiation. Our findings underscore a molecular and functional coupling between inducing pluripotency and obtaining "trans-differentiated" somatic cells via OSKM induction, and have implications on defining molecular trajectories assumed during different cell reprogramming methods.
Main Text
The identity of somatic cells can be converted to variant extents by ectopic expression of exogenous factors 1, 2 . The latter include the ability to directly reprogram somatic cells to pluripotency via ectopic expression of exogenous transcription factors, canonically OSKM, in Leukemia Inhibitory factor (LIF) containing mouse ES growth conditions 2 . Isolated iPSCs (OSKM-iPSC) can be subsequently directed towards a variety of lineages by distinct differentiation protocols. Since their initial discovery, a variety of factors can substitute or complement OSKM components to yield iPSCs at greater efficiencies and kinetics 3, 4 . Importantly, cytokines and small molecules used can directly influence epigenetic reprogramming by modulating endogenous signaling and chromatin remodeling pathways (e.g. LIF/Stat3 signaling pathway activation, Vitamin C induced epigenetic changes, BMP4 promotion of naïve pluripotency, TCF3 target gene derepression following GSK3 inhibition etc.) 5, 6 .
A different strategy for lineage conversion, termed somatic cell transdifferentiation, entails ectopic expression of somatic lineage master regulators that induce mature somatic cells cell transformation into a different cell type without going through a pluripotent configuration (e.g. MyoD converts fibroblasts into muscle cells, C/EBPα converts Pro-B cells into macrophage-like cells, Mitf converts fibroblasts into melanocyte-like cells) [7] [8] [9] . Recently however, a new approach combining pluripotency induction and somatic trans-differentiation, called OSKM mediated trans-differentiation (OSKM-TD), has been introduced as a mean to directly interconvert somatic cells without acquiring pluripotency [10] [11] [12] . In this approach, instead of applying defined somatic lineage transcription factors, the four Yamanaka pluripotency reprogramming factors are briefly induced to periods as short as 3-10 days to presumably only induce a partially reprogrammed plastic state 10, 11 . By providing lineage-specifying media that does not contain conventional pluripotency promoting cytokines like LIF, reprogramming of such intermediate supposedly "plastic" state is shifted towards a desired somatic cell fate, without attaining a state of pluripotency. Notably, by using this approach to achieve somatic cell trans-differentiation, typically higher quality and more fully programmed cells are produced, as compared to those achieved via ectopic expression of somatic lineage promoting factors 11 .
Several experimental pillars were provided to exclude acquisition of pluripotency in the OSKM-TD approach [10] [11] [12] . First, brief OSKM induction of only up to maximum of 10 days was applied, which was deemed as insufficient to yield iPSCs 10, 11 . Further, these studies reported failure to detect Nanog-GFP expression or transcription in bulk cultures assayed at different time points during OSKM-TD 10, 11 . Absence of LIF and utilization of JAK1 small molecule inhibitors to block LIF/JAK1/Stat3 signaling were also used to exclude acquisition of pluripotency. Despite of the above, lineage tracing tools to unequivocally exclude acquisition of pluripotency during this manipulation in the rare cells that successfully trans-differentiate among the donor cell population (reported efficiencies <1%), were not used [10] [11] [12] . Thus it remains unclear whether somatic cells produced by this technique are in fact trans-differentiated or rather preferentially transiently go through a state of induced pluripotency and then differentiate to a somatic lineage according to the differentiation media conditions used in OSKM-TD protocols.
Our interest to carefully examine the OSKM trans-differentiation phenomena was evoked via multiple results that strengthened the possibility the iPSCs may still be formed under suboptimal reprogramming conditions, and that brief OSKM induction can overcome differentiation signals and leads to rapid iPSC formation. First, we were able to obtain Nanog-GFP+ iPSCs at low efficiency from different Doxycycline (Dox) inducible OSKM transgenic systems with as little as 3 days of Dox induction (Fig. 1a) . These results are consistent with previous reports that obtained iPSC after brief OSKM induction and existence of privileged donor somatic cells in fibroblasts that rapidly commit and convert into iPSC [13] [14] [15] . Further, when Oct4-GFP reporter fibroblast cells were subjected to OSKM transduction in Cardiogenic or neural stem cells (NSCs) growth conditions, instead of pluripotency conditions, we were still able to obtain GFP expression ES-like colonies and observed "hybrid" colonies with Oct4-GFP+ cells in the center of the colony while their edges showed clear neuronal differentiation signs and lack of Oct4-GFP ( Supplementary Fig. 1 ). The results above emphasized the need to exclude the possibility that iPSCs may still be formed under suboptimal reprogramming conditions and may be a considerable source for mature trans-differentiated cells obtained via OSKM-TD approaches 10, 11 .
We next moved to engineer an exacting system to track transient acquisition of pluripotency during in vitro reprogramming. We aimed to design a genetic tracing system for endogenous Nanog reactivation, as it is an important factor for establishing pluripotency in vivo and in vitro, as its reactivation occurs at the late and final stages of iPSC formation in mouse and human cells 10, 11, 16, 17 . Consistently, the previous OSKM-TD studies heavily focused on excluding Nanog reactivation and transcriptional detection during OSKM mediated trans-differentiation in the bulk reprogramming cultures 10,11 as conclusive evidence for excluding acquisition of pluripotency. We designed a reprogrammable system in which transient activation of Nanog in the process of reprogramming can be easily monitored by permanent tdTomato fluorescence activation, indicating that pluripotency was achieved, even if only temporarily. We first cross-bred Subsequently, we generated a BAC recombineered Nanog-CreER targeting construct, which introduces a knock-in Tamoxifen inducible CreER cassette under the control of endogenous Nanog promoter (Fig. 1C) . The quadruple knock-in ESC line was subcloned after PCR and Southern Blot validation for correct targeting by Nanog-CreER knock in allele ( Supplementary Fig 2A. ). The latter ESCs were microinjected in host blastocyst to generate chimeric animals, from which transgenic fibroblasts were extracted for experimental analysis (Fig. 1B) .
We validated the sensitivity and specificity of our system. Mouse ESCs turned on tdTomato rapidly after 48 hours of 4OHT induction (100% of ES colonies), while no fluorescence was detected in ESCs passaged over extended time in the absence of 4OHT ( Supplementary Fig 2B-C) . MEF cells expanded with or without Dox in the absence of 4OHT, did not show any reactivation of tdTomato, further indicating 100% specificity of the system and excluding leakiness during expansion or reprogramming (Fig. 1D ). The fidelity (sensitivity) of the reporter system was evaluated by reprogramming the transgenic MEFs to pluripotency by adding Dox and 4OHT to the medium and withdrawing both molecules at two time points: 6, and 10 days. Adding 4OHT alone did not produce any colonies, while Dox alone did not produce any tdTomato+ colonies (Fig.   1D ). Formed ES-like colonies for each of the conditions, at the abovementioned time points (48 colonies for each group), were randomly subcloned and grown for another 5-6 days at which point the presence of tdTomato+ clones was assessed as a percentage of the total number of developed validated iPSC clones (AP+/OCT4+/SSEA1+ independent of Dox). We found the fidelity of our system to be ~85% and ~92% for iPSCs obtained after 6 and 10 days of Dox induction, respectively ( Fig. 1D ). Lack of 100% sensitivity might be explained by a number of non-mutually exclusive possibilities: limitations of the Nanog knock-in allele activation, mono-allelic expression of Nanog 19 , or reflect true biological outcome particularly that Dox/4OHT pulses are given for a limited period of time during reprogramming (only 6 or 10 days). Nevertheless, the above results validate the ability of the system to specifically document authentic acquisition of pluripotency during iPSCs reprogramming and with very high sensitivity.
We subjected Nanog tracing system and reporter engineered MEF cells to previously reported OSKM trans-differentiation experiments converting fibroblasts into cardiomyocytes or neural stem cells (NSCs). Importantly, protocols of experiments and media used were meticulously followed as published in the relevant papers 10, 11 . Direct reprogramming of Nanog-CreER reporter MEFs to NSCs was done in knockout DMEM medium with 10% KSR/5% FBS and with Dox and 4OHT for the first 3-6 days ( Fig.   1A ). Thereafter, Dox and 4OHT were withdrawn from the medium, and cells were grown in neural reprogramming medium (DMEM-F12 and Neurobasal medium mixed by 1:1 and supplemented with FGF2 and EGF) until NSC colonies were formed by day 13 (Fig.   1B ). From day 4 onwards JAK1 inhibitor (J1I) was added to the culture medium. At day 13, formed colonies were subcloned and grown in NSC medium on Poly-D-Lysine and Laminin coated plates. All experiments of OSKM mediated trans-differentiation of MEFs into cardiomyocytes or NPCs were carried out in LIF-free mediums, and without the presence of feeder cells. Indeed Sox1+ NSC colonies were apparent in this protocol, and could be subcloned expanded as stable line, and were expectedly responsive for induced differentiation into differentiated Tuj1+ neurons ( Supplementary Fig. 3A-B) . RNA-seq analysis confirmed their transcriptional similarity to primary embryo derived NSCs, and their distinct form mouse fibroblasts or ESCs ( Supplementary Fig. 3C ). Remarkably, ~88% of Sox1+ NPC colonies were tdTomato+ indicating acquisition of pluripotency during OSKM mediated somatic cell conversion
Conversion of MEFs into cardiomyocytes was done in reprogramming media
containing 15% fetal bovine serum (FBS) and 5% knock-out serum replacement (KSR) with added JAK1 inhibitor (JI1) for 6 days, followed by switch to 1% FBS and 14% KSR and JAK1 inhibitor for 3 days (Fig. 2D ). Dox and 4OHT were added to the medium at day 1 and continuously kept in the medium until day 6-9. From day 9 onwards, cells were cultured in chemically defined RPMI/N2B27 medium, with the cardio-inductive growth factor BMP4 for the first 5 days (Fig. 2D ). Colonies were allowed to develop for up to 21 days or until beating cardiomyocytes were noticed in the plated cells. Indeed by applying this protocol we were able to achieve cardiomyocytes that expressed early and late cardiomyocytes markers (Myosin, cardiac Troponin) many of which showed beating rhythmicity ( Fig. 2f and Supplementary Fig. 3D ). Remarkably however, ~93% of Myosin positive cardiomyocytes colonies were tdTomato+ indicating that they reactivated pluripotency during their conversion ( Fig. 2E-F, Supplementary Fig. 3E ,
Supplementary Videos 1-6).
We next aimed to apply a different lineage tracing system for evaluating acquisition of pluripotency during OSKM-TD, by determining whether the inactive X chromosome in donor female somatic cell lines undergoes reactivation. It has been well established that X chromosome reactivation is a late and specific hallmark feature for reactivation of pluripotency and is followed by random X inactivation in clonal iPSC derived differentiated progenies 20 . To track X chromosome reactivation and inactivation dynamics, we crossed female Rosa26 M2RtTa +/+ and m.Col1a-TetO-OSKM +/+ mice 18 with male mice carrying an X-linked GFP reporter transgene 21 , and purified GFP-tail tip fibroblasts form female mice (i.e., all GFP-reprogrammable cells carry the GFP transgene on the inactive X chromosome) ( Fig. 2H) . Remarkably, GFP fluorescence was identified in >90% of OSKM-TD NSC and cardiac colonies (Fig. 2H) , and in 100% of iPSCs obtained. Importantly, reprogramming of female derived GFP-Pro-B lymphocytes into macrophage like cells by C/EBPα overexpression 22 , did not yield any GFP+/Mac+ colonies (Fig. 2H) , excluding promiscuous and non-specific X chromosome reactivation in any transdifferntiation protocol applied. The latter results reinforce Nanog reactivation lineage tracing results ( Fig.2 A-G) , and reiterate the conclusion that the vast majority of OSKM-TD derived cells pass through a pluripotent state before transitioning towards somatic differentiation.
In the next set of experiments, we set out to explore a functional role for endogenous Nanog reactivation in OSKM mediated trans-differentiation, as the latter event has been shown not only to mark final stages of pluripotency acquisition, but to also synergistically boost iPSC reprogramming by OSKM 23 . We utilized previously described Nanog -/knock out and Nanog +/+ ESCs 23 and as recently published, Nanog -/-ESCs can be expanded in 2i/LIF/15% KSR enriched conditions while maintaining their pluripotency 24, 25 (Supplementary Fig. 4A ). Reprogramming of Nanog -/-MEFs and secondary Nanog wild type MEFs to pluripotency was done following TetO-OSKM transduction and plating in two triplicates of 1^10 3 cells plated on day 0 for each time point and medium condition, in a 6 well plate, followed by adding Dox at day 1 to the either with or without 2i supplement. Formed colonies at day 6 and 10 were evaluated and counted by alkaline phosphatase staining. Reprogramming efficiency to pluripotency of Nanog -/-MEFs as compared to Nanog wild type showed a reduction of 90% and 55% in efficiency at days 6 and 10, respectively ( Fig. 2I and Supplementary Fig. 4B-D) .
Next, Nanog -/and Nanog +/+ MEFs were used in OSKM mediated trans-differentiation of NSCs and cardiomyocytes. The efficiency of trans-differentiation was evaluated as the number of colonies stained positive for NSCs or cardiomyocytes markers respectively, relative to the total number of colonies emerged after OSKM induction. Experiments were carried out in two triplicates of 1^10 3 cells plated at day 0, in a 6 well plate, revealing a reduction of efficiency by 80-85% in the Nanog -/-MEFs as compared to Nanog +/+ wild type cells ( Fig. 2I and Supplementary Fig. 4D ). Collectively, these results show that endogenous Nanog reactivation is functionally coupled to OSKM-Transdifferntiation efficiency, and at an equivalent robustness to that observed during OSKM-iPSC formation ( Fig. 2I and Supplementary Fig. 4D ).
Finally, OSKM mediated trans-differentiation regimens make use of mediums devoid of LIF or with added JAK-Inhibitor, which block Stat3 pathway signaling, assuming these conditions completely prevent the formation of pluripotent iPSCs 10, 11 .
Given that induced reprogramming OSKM transgenes has been previously found sufficient to support expansion of pluripotent cells form non-permissive strains like NOD in LIF only conditions 26 , and that they also boost EpiSC reprogramming 24 , we wondered if they can completely supplement for exogenous LIF/Stat3 signaling. To tackle the latter issue, reprogramming of Nanog CreER reporter MEFs to pluripotency was done with added JAK1-Inhibitor and LIF-free N2B27 medium (Supplementary Fig. 5A ).
Transgene dependent iPSCs reprogrammed in these conditions were derived, expanded and shown to possess bona fide pluripotent capacity as evident by, positive staining for alkaline phosphatase, SSEA1, Nanog and mature teratoma formation ( Supplementary   Fig. 5A-D) . These results corroborate previous finding that Stat3 can be dispensable for re-establishing pluripotency 6 , and that exclusion of LIF/Stat3 is not an unequivocal proof for lack of acquisition of pluripotency when providing exogenous pluripotency factor transgenes. It is also important to note that a variety of ingredients claimed to increase trans-differentiation efficiency, are well known boosters for iPSC induction and naïve pluripotency maintenance in mice, including BMP4 cytokine 27 and Knockout serum replacement (KSR) that contains L-ascorbic acid (Vitamin C) 5, 28 .
Conversion of cell fate in vitro or in vivo carries great potential for the future of regenerative medicine. While there are often different routes of reprogramming to achieve a certain defined cell type, each might carry a variety of technical and functional advantages and disadvantages that are of importance to be explored 29 . Simultaneously, it is critical to study the molecular paths and trajectories assumed by these reprogrammed cells 30, 31 . As such, we revisited recently described methods to convert somatic cell types by canonical iPSC reprogramming factor expression 11, 32 , and concluded that while the technique of OSKM mediated trans-differentiation may be a relevant and safe way to fully reprogram differentiated cells, most of the latter cells are obtained following temporarily reaching a pluripotent state and rapidly differentiating according to the media used. While our study cannot absolutely exclude that some trans-differentiated cells are 
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Supplementary Figure 3: Validation and characterization of OSKM-TD cells. A.
Immunostaining of NSC markers: Nestin, Sox1 and Sox2 in primary brain derived NSCs 
Experimental procedures
Generation of Reprogrammable Nanog-CreER Reporter Mice
Homozygote Rosa26 LoxP-stop-LoxP tdTomato +/+ mice were a kind gift by Prof. Non-essential amino acids, 1% penicillin/streptomycin, 0.1 mM β-mercaptoethanol and 15% FBS (Biological Industries). Developed mESCs colonies were expanded as single clonal lines. In order to make a targeting construct for inserting CreERT2 gene in frame with mouse Nanog we used Red/ET based recombineering technique (GeneBridges).
Briefly, creERT-pgk-gb2-Hygromycin cassette was inserted into a BAC covering murine Nanog gene region in a way that starting codon of Nanog now became starting codon of CreERT2. Next, BAC fragment containing CreERT insert and appropriate homology arms were cloned into pDTA plasmid encoding Diphtheria Toxin gene cassette used for negative selection in mESCs. BAC recombineered Cre-ER PGK-Hygro construct was linearized with Sca1 and electroporated into the triple allele knock-in mESCs.
Hygromycin resistant clones (10 days) were subcloned and screened by southern blot using a 3' external probe and a PCR creating a 2kb amplification of the 5' arm, with upstream forward primer and reverse primer from the Nanog Cre-ER knock-in. Correctly targeted clones were transfected with Flippase encoding construct, to remove Hygromycin resistant cassette. Properly targeted mESCs were microinjected into blastocysts to create chimeric animals. At day E13.5 embryos were extracted and used to derive MEFs containing the reporter system with all four knock-in alleles.
Southern blot analysis
Genomic DNA was extracted from each Hygromycin resistant targeted subclones. 10-15 g of genomic DNA was digested with Mfe1 restriction enzyme for 5 hours and separated by gel electrophoresis. The DNA was transferred to a nitrocellulose membrane that was next hybridized with a radioactive labeled probe and developed using ECL (Thermo). Nanog +/+ and Nanog -/-ESCs 23 were rendered transgenic for a constitutively expressed Puromycin resistance cassette 15 , and were subsequently microinjected into host blastocysts. Chimeric embryos were used to derive MEFs, which were selected by Puromycin (2microg/ml final concentration) resistance for at least 3 days then used for transduction and reprogramming in 2i/LIF/15% KSR enriched conditions. In Figure 1a and Supplementary Figure 1 , MEFs were obtained from Rosa26-m2rtTA (+/-);mCol-OSKM (+/-) mice (Jackson Laboratories #011004), Rosa26-m2rtTA (+/-); mCol STEMCCA-OKSM (+/-) mice (Jackson Laboratories #011001) that were bred with Oct4-GFP or Nanog-GFP knock-in reporter mice 34. NGFP4 iPSC line was generated as previously described 34 .
iPSC reprogramming by OSKM
Trans-differentiation Reprogramming
Reprogramming of MEFs into cardiomyocytes was done in media containing: DMEM with supplemented 15% FBS and 5% KSR with added JAK1 inhibitor (Calbiochem 420099, 0.5 M) for 6 days, followed by switch to 1% FBS and 14% KSR and JAK1 inhibitor for 3 days. The medium was supplemented with 1% L-Glutamine, 1% Non-essential amino acids, 1% penicillin/streptomycin and 0.1 mM βmercaptoethanol. Doxycycline hyclate and 4-Hydroxytamoxifen were added to the medium at day 1 and continuously kept in the medium until day 6-9. From day 9 onwards, cells were cultured in chemically defined RPMI (gibco 21875-034)/N2B27 medium (0.5XN2, 1XB27) with the cardio-inductive growth factor BMP4 (Peprotech 120-05ET) for the first 5 days, and supplemented with BSA fraction V 0.05% (gibco 15260-037) 1% L-Glutamine, 1% Non-essential amino acids, 1% penicillin/streptomycin and 0.1 mM β-mercaptoethanol. Colonies were allowed to develop for 21 days or until beating cardiomyocytes were noticed among the plated cells.
Reprogramming of MEFS to NSCs was carried out in knock-out DMEM medium (gibco 10829-018) with 10% KSR (Invitrogen), 5% FBS, 1% L-Glutamine, 1% Nonessential amino acids, 1% penicillin/streptomycin, 0.05 mM β-mercaptoethanol and with Dox+4OHT for the first 3-6 days. Thereafter, Dox and 4OHT were withdrawn from the medium, and cells were grown in neural reprogramming medium: DMEM-F12 and Neurobasal medium mixed by 1:1 and supplemented with BSA fraction V 0.05%, 1XN2, 1XB27, 1% L-Glutamine, 1% Non-essential amino acids, 1% penicillin/streptomycin and 0.1 mM β-mercaptoethanol with FGF2 (Peprotech 450-33, 20ng/mL) and EGF (Peprotech 315-09,20ng/mL), until NSC colonies were formed by day 13. From day 4 onwards JAK1 inhibitor was added to the culture medium. At day 13, formed colonies were subcloned and grown in NSCs medium on Poly-D-Lysine and Laminin coated plates. We note that OSKM activation by Dox for 3 days was sufficient for NSCs transdifferentiation, and 6 days activation for cardiomyocytes trans-differentiation, though substantially fewer colonies developed at these minimally required activation periods as reported in the original papers 10, 11 . When applying OSKM-TD protocols without 4OHT or with ETOH as a control replacement, all cardiomyocyte and NSC colonies were negative for tdTomato signal, excluding leakiness of this system under OSKM-TD conditions as similarly observed with iPSCs (Fig. 1D) .
Brain-derived NSCs were derived from E13.5 BDF2 mouse embryos according to standard protocols, and were cultured in DMEM/F12 (Invitrogen) supplemented with 1XB27 and 1XN2 cell-supplements (Life Technologies), 0.01% Fraction V BSA 7.5 % solution (Life Technologies), 1% Penicillin-streptomycin and 10ng/ml bFGF (R&D) and 20ng/ml EGF (Life Technologies). Mouse embryo micromanipulation and imaging. Pluripotent mouse ESCs/iPSCs were injected into BDF2 diploid blastocysts, harvested from hormone primed BDF1 6 week old females. Microinjection into BDF2 E3.5 blastocysts placed in M16 medium under mineral oil was done by a flat-tip microinjection pipette. A controlled number of 10-12 cells were injected into the blastocyst cavity. After injection, blastocysts were returned to KSOM media (Zenith) and placed at 37 o C until transferred to recipient females. Ten to fifteen injected blastocysts were transferred to each uterine horn of 2.5 days post coitum pseudo-pregnant females. The latter experiments were approved by Weizmann Institute IACUC (00330111-2).
Genetic tracing for X chromosome reactivation in reporter murine female cells
Viral production
For primary cell reprogramming, ~6x10 6 T-293 cells in a 10 c"m culture dish were transfected with a solution made of 770μL DMEM (Invitrogen) together with 50μl of TransIT ® -LT1, Δ8.9 (8.5 μg), VSV-G (5.5 μg) and 11μg of the lentiviral target plasmid (FUW-M2rtTA, FUW-TetO-STEMCCA-OKSM, FUW-TetO-OSKM). Viral supernatant was harvested 48 and 72 hours post transfection, filtered through 0.45micron sterile filters (Nalgene) and added freshly to the reprogrammed cells. MSCV-C/EBPα retrovirus stocks were prepared by transient transfection of Phoenix-Eco cells using Fugene (Roche), and supernatants were harvested 48 hours later and filtered. Pro-B cell expansion on OP-9 cells and transduction with C/EBPα was conducted as previously described 34 .
Immunostaining
Nanog-CreER iPSCs in LIF-free N2B27 medium with supplemented JAK1-Inhibitor and Dox, and Nanog -/-iPSCs were cultured on glass cover slips (13 mm 1.5H; Marienfeld, 0117530), washed three times with PBS and fixed with 4% paraformaldehyde for 10 minutes at room temperature. Cells were then permeabilized and blocked in 0.1% Triton, 0.1% Tween, and 5% FBS in PBS for 15 min at room temperature. Primary antibodies were incubated for 2 hours at room temperature and then washed with 0.1% Tween and 1% FBS in PBS three times. Next, cells were incubated with secondary antibody for 1 hour at room temperature, washed and counterstained with DAPI, mounted with Shandon Immu-Mount (Thermo Scientific) and imaged. All antibodies in this study have been validated in the literature and by our internal tests on primary cell lines (data not shown).
